The online version of this article (https://doi.org/10.1186/s12885-018-4030-5) contains supplementary material, which is available to authorized users.
Oestrogen receptors (ER) have a well-established role to the initiation, progression and regulation of responses to treatment of breast, prostate, and lung cancers. Previous data indicates altered ER expression in oesophageal cancers (OC). However the role of ER subtypes and ER specific inhibitors in the regulation of OC progression remains unclear. This study sought to assess levels of ERα and ERβ in OC. The effects of highly selective ER antagonists on cell proliferation and apoptosis in two OC adenocarcinoma cell lines was also studied.
ERα and ERβ expression profiling in paired normal oesophageal mucosa and tumour tissues (n = 34; adenocarcinoma n = 28; squamous cell carcinoma n = 6) was performed using quantitative reverse transcription polymerase chain reaction (qRT-PCR). Correlation between levels of ER with the clinico-pathological features for OC was determined. The effect of selective ER antagonists on proliferation of OE33 and OE19 OC cell lines was studied.
ERα and ERβ mRNA expression was significantly higher (p < 0.05) in tumour tissues relative to their paired normal mucosa and correlated inversely with survival outcome (p < 0.05). Upregulation of ERα mRNA correlated with higher pathological T-stage (p < 0.05) and lymph node metastasis (p < 0.05) while ERβ mRNA upregulation correlated with positive vascular invasion (p < 0.05). A significant concentration-dependent inhibition of proliferation in OE33 and OE19 cell lines was induced by a highly-selective ERα antagonist (MPP) and an ERβ specific antagonist (PHTPP) (p < 0.05). Moreover, anti-oestrogens induced cell death through stimulation of apoptotic caspase activity.
These findings indicate that the ER system is involved in OC progression and thus may provide a novel target for the treatment of OC.
Additional file 1: Figure S1. Identification of suitable reference genes. Reference genes expression stability was analysed using geNorm and NormFinder. Figure S2. E2 treatment does not alter proliferation of OE33 and OE19 cells. Bar chart demonstrates the effect of increasing dose of E2 on OE33 and OE19 cell lines proliferation. (PDF 348 kb)12885_2018_4030_MOESM1_ESM.pdf
Umar SB, Fleischer DE. Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol. 2008;5(9):517–26. CrossRef
Mathieu LN, et al. Age and sex differences in the incidence of esophageal adenocarcinoma: results from the surveillance, epidemiology, and end results (SEER) registry (1973–2008). Dis Esophagus. 2013; p. n/a-n/a
Bodelon C, et al. Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women. Cancer Prev Res (Phila). 2011;4(6):840–50. CrossRef
Morita M, et al. Gender differences in prognosis after esophagectomy for esophageal cancer. Surg Today. 2013:1–8.
Jia M, Dahlman-Wright K, Gustafsson J-Å. Estrogen receptor alpha and beta in health and disease. Best Prac Res Clin Endocrinol Metabol. 2015;29(4):557–68. CrossRef
Jassam N, et al. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes’ staging. Oncol Rep. 2005;14(1):17–21. PubMed
Wang BJ, et al. Hormonal and reproductive factors and risk of esophageal cancer in women: a meta-analysis. Dis Esophagus. 2015; p. n/a-n/a
McClelland RA, et al. Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. Cancer Res. 1990;50(12):3545–50. PubMed
Wilkins H, et al. Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing c-myb protein, and decreasing transcription of the anti-apoptotic protein bcl-2. Tumor Biol. 2010;31(1):16–22. CrossRef
Akgun H, Lechago J, Younes M. Estrogen receptor-beta is expressed in Barrett's metaplasia and associated adenocarcinoma of the esophagus. Anticancer Res. 2002;22(3):1459–61. PubMed
Liu L, Chirala M, Younes M. Expression of estrogen receptor-beta isoforms in Barrett's metaplasia, dysplasia and esophageal adenocarcinoma. Anticancer Res. 2004;24(5A):2919–24. PubMed
Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Asp Med. 2006;27(4):299–402. CrossRef
Ung M, et al. Effect of estrogen receptor α binding on functional DNA methylation in breast cancer. Epigenetics. 2014;9(4):523–32.
- Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro
Syed Yousef Iftikhar
- BioMed Central
Neu im Fachgebiet Onkologie
Mail Icon II